alpha-Methyl-4-deoxy-4-[(18)F]fluoro-D-glucopyranoside

BEHAVIORAL2 trials

Sponsors

Medical University of Vienna, Jonsson Comprehensive Cancer Center

Conditions

Lung AdenocarcinomaType2 Diabetes Mellitus

Phase 1

An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer

RecruitingNCT05558904

Jonsson Comprehensive Cancer CenterLung Adenocarcinoma

Start: 2023-01-19End: 2027-10-01Target: 60Updated: 2025-11-10

Unknown Phase

Study to Develop a Kinetic Model for FDG and Me4FDG in Kidneys of Type 2 Diabetic Patients

Medical University of ViennaType2 Diabetes Mellitus

Start: 2017-02-22End: 2020-12-31Target: 20Updated: 2019-12-12

Related Papers

In vivo assessment of safety, biodistribution, and radiation dosimetry of the [<sup>18</sup>F]Me4FDG PET-radiotracer in adults.

2024-05-15

Response evaluation of SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus using <sup>18</sup>F-FDG PET/MRI

BMJ Open Diabetes Research & Care2020-03-018 citations